BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Inflammatory bowel diseases
1
Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring
12/26/2025 10:27:31 AM | Browse: 64 | Download: 254
2
Enteric nervous system as a therapeutic target in gastrointestinal disorders
12/5/2025 11:28:03 AM | Browse: 79 | Download: 252
3
Dialister-driven succinate accumulation is associated with disease activity and postoperative recurrence in Crohn’s disease
12/3/2025 9:10:08 AM | Browse: 89 | Download: 344
4
Comparative analysis of the pathogenesis in Crohn’s disease and ulcerative colitis
8/5/2025 8:25:48 AM | Browse: 127 | Download: 429
5
Anti-vaccine antibodies against measles, rubella, parotitis and hepatitis B in children with inflammatory bowel disease and healthy controls
6/16/2025 10:38:20 AM | Browse: 122 | Download: 621
6
Vedolizumab serum trough concentrations with and without thiopurines in ulcerative colitis: The prospective VIEWS pharmacokinetics study
12/18/2024 7:36:01 AM | Browse: 149 | Download: 656
7
Editor-in-Chief articles of choice and comments from January to June 2024
9/10/2024 9:27:23 AM | Browse: 120 | Download: 513
8
Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease
6/25/2024 10:41:21 AM | Browse: 148 | Download: 672
9
Prevalence and risk factors of depression among patients with perianal fistulizing Crohn’s disease
5/16/2024 7:58:19 AM | Browse: 251 | Download: 1094
10
Interaction between diet and genetics in patients with inflammatory bowel disease
3/28/2024 12:17:56 PM | Browse: 259 | Download: 991
11
Duodenal Crohn's disease: Case report and systematic review
3/7/2024 9:32:28 AM | Browse: 330 | Download: 994
12
Editor-in-Chief articles of choice and comments at the year-end of 2023
1/6/2024 12:15:34 PM | Browse: 232 | Download: 787
13
Cardiovascular implications of inflammatory bowel disease: An updated review
11/23/2023 8:41:50 AM | Browse: 348 | Download: 1035
14
Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study
7/13/2023 8:46:32 AM | Browse: 449 | Download: 1713
15
Spatial cluster mapping and environmental modeling in pediatric inflammatory bowel disease
6/16/2023 9:52:18 AM | Browse: 458 | Download: 1616
16
Study of the roles of caspase-3 and nuclear factor kappa B in myenteric neurons in a P2X7 receptor knockout mouse model of ulcerative colitis
6/7/2023 6:39:13 AM | Browse: 450 | Download: 1333
17
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases
5/26/2023 8:34:05 AM | Browse: 295 | Download: 865
18
Study of tumor necrosis factor receptor in the inflammatory bowel disease
5/11/2023 8:05:04 AM | Browse: 354 | Download: 1052
19
Vaccination coverage in children with juvenile idiopathic arthritis, inflammatory bowel diseases, and healthy peers: Cross-sectional electronic survey data
3/6/2023 9:33:15 AM | Browse: 392 | Download: 1279
20
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases
1/20/2023 1:48:20 PM | Browse: 500 | Download: 1261
21
Advancing the precision management of inflammatory bowel disease in the era of omics approaches and new technology
1/6/2023 2:52:58 AM | Browse: 434 | Download: 1320
22
Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease
12/27/2022 10:06:45 AM | Browse: 469 | Download: 1321
23
Evaluation of gut dysbiosis using serum and fecal bile acid profiles
12/2/2022 12:50:19 PM | Browse: 507 | Download: 1244
24
Role of short chain fatty acids in gut health and possible therapeutic approaches in inflammatory bowel diseases
9/27/2022 1:00:17 PM | Browse: 727 | Download: 1961
25
Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease
9/23/2022 9:45:22 AM | Browse: 692 | Download: 1691
26
Epidemiology of inflammatory bowel diseases in the state of Rio Grande do Sul, Brazil
8/10/2022 8:23:14 AM | Browse: 811 | Download: 2554
27
Shared decision-making in the management of patients with inflammatory bowel disease
7/13/2022 7:30:59 AM | Browse: 609 | Download: 1402
28
Novel drug delivery systems for inflammatory bowel disease
5/12/2022 8:42:29 AM | Browse: 800 | Download: 1753
29
c-MET immunohistochemical expression in sporadic and inflammatory bowel disease associated lesions
3/30/2022 3:20:26 PM | Browse: 718 | Download: 1635
30
“Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel disease”: A letter to the editor
2/24/2022 9:46:00 AM | Browse: 712 | Download: 1372
31
Mammalian target of rapamycin; novel insight for management of inflammatory bowel diseases
1/25/2022 7:27:40 AM | Browse: 780 | Download: 1925
32
Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders
12/27/2021 5:24:00 AM | Browse: 651 | Download: 1568
33
Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment
12/10/2021 9:08:48 AM | Browse: 756 | Download: 1909
34
Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor
12/10/2021 9:08:48 AM | Browse: 779 | Download: 1594
35
Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease
9/3/2021 8:21:31 AM | Browse: 759 | Download: 1804
36
Viral infections in inflammatory bowel disease: Tips and tricks for correct management
7/19/2021 2:10:40 PM | Browse: 682 | Download: 1884
37
Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil
6/18/2021 5:06:16 AM | Browse: 872 | Download: 2905
38
Receptor for advanced glycation end-products axis and COVID-19 in inflammatory bowel diseases: A dangerous liaison?
5/13/2021 10:05:39 AM | Browse: 699 | Download: 1728
39
Risk stratification and geographical mapping of Brazilian inflammatory bowel diseases patients during COVID-19 outbreak: Results from a nationwide survey
3/25/2021 11:42:15 AM | Browse: 832 | Download: 2467
40
Helicobacter pylori: Commensal, symbiont or pathogen?
2/20/2021 2:51:13 AM | Browse: 1164 | Download: 2434
41
Assessment of disease activity in inflammatory bowel diseases: Non-invasive biomarkers and endoscopic scores
12/13/2020 7:01:09 AM | Browse: 992 | Download: 2554
42
Primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome associated with inflammatory bowel disease: A case report and systematic review
9/22/2020 3:17:13 AM | Browse: 962 | Download: 2575
43
Potential of the ellagic acid-derived gut microbiota metabolite – Urolithin A in gastrointestinal protection
6/21/2020 2:15:44 PM | Browse: 1119 | Download: 2108
44
Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status
6/8/2020 3:14:59 AM | Browse: 982 | Download: 1924
45
Increased circulating circular RNA_103516 is a novel biomarker for adult inflammatory bowel disease
11/7/2019 1:35:59 AM | Browse: 1060 | Download: 3138
46
Cell membrane and bioactive factors derived from mesenchymal stromal cells: Cell-free based therapy for inflammatory bowel diseases
9/25/2019 3:03:24 AM | Browse: 1024 | Download: 1987
47
Role of NLRP3 inflammasome in inflammatory bowel diseases
9/7/2019 4:43:36 AM | Browse: 1023 | Download: 1832
48
Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment
8/21/2019 9:19:18 AM | Browse: 1169 | Download: 2230
49
Inflammatory bowel disease patient profiles are related to specific information needs: A nationwide survey
8/14/2019 1:31:33 PM | Browse: 1018 | Download: 2684
50
Intestinal enteroids/organoids: A novel platform for drug discovery in inflammatory bowel diseases
8/14/2019 1:31:33 PM | Browse: 1144 | Download: 2049
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345